Concerto, C., Chiarenza, C., Di Francesco, A., Natale, A., Privitera, I., Rodolico, A., Trovato, A., Aguglia, A., Fisicaro, F., Pennisi, M., Bella, R., Petralia, A., Signorelli, M
As a nurse-owned and operated concierge wellness service, our mission is simple: provide safe, personalized, clinically guided care that helps people feel better, recover faster, and avoid unnecessary hospital visits whenever appropriate
Andrew Huberman Peptides: How a Regular Patient Would Get Access At a glance Andrew Huberman has discussed BPC-157, TB-500, Sermorelin, and GHK-Cu on the Huberman Lab podcast The FDA banned bulk compounding of several peptides in late 2023 under its Category 2 list BPC-157 and TB-500 are not FDA-approved drugs and carry limited human trial data Sermorelin and CJC-1295/Ipamorelin remain available through 503A/503B compounding pharmacies Insurance almost never covers compounded peptide prescriptions A prescriber visit, baseline labs, and follow-up monitoring are standard requirements Telemedicine peptide clinics have expanded access but vary widely in clinical rigor The Endocrine Society has not endorsed peptide secretagogues for anti-aging use What Peptides Has Andrew Huberman Discussed
The result is increased NAD+ levels, but through conservation rather than supplementation
Cloudiness or settling material indicates incomplete dissolution or degradation
